Next Article in Journal
Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma
Next Article in Special Issue
Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
Previous Article in Journal
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
Previous Article in Special Issue
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
 
 

Order Article Reprints

Journal: Vaccines, 2022
Volume: 10
Number: 373

Article: Gender and AB0 Blood Type Differences in a Unicentric Group of University Professors in Southern Italy Who Received the Vaxzevria COVID-19 Vaccine: A Cross-Sectional Survey of Vaccine Side Effects, Attitudes, and Hesitation
Authors: by Silvana Mirella Aliberti, Luigi Schiavo, Giovanni Boccia, Emanuela Santoro, Gianluigi Franci, Alessandro Ruggiero, Francesco De Caro and Mario Capunzo
Link: https://www.mdpi.com/2076-393X/10/3/373

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop